LGND : Summary for Ligand Pharmaceuticals Incorpor - Yahoo Finance

U.S. Markets closed

Ligand Pharmaceuticals Incorporated (LGND)


NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
111.17-0.02 (-0.02%)
At close: 4:00PM EDT
People also watch
NBIXINCYVICLALKSPGNX
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close111.19
Open111.19
Bid0.00 x
Ask0.00 x
Day's Range110.45 - 111.90
52 Week Range87.50 - 139.79
Volume122,933
Avg. Volume265,831
Market Cap2.33B
Beta1.08
PE Ratio (TTM)-1,407.22
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield0.00 (0.00%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube3 days ago

    Ligand Pharmaceuticals, Inc. – Value Analysis (NASDAQ:LGND) : April 27, 2017

    Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Ligand Pharmaceuticals, Inc. a score of 47. Our analysis is based on comparing Ligand Pharmaceuticals, Inc. with the following peers – Amgen Inc., GTx, Inc., Spectrum Pharmaceuticals, Inc., Eli Lilly and Company, Merck & Co., Inc., Bristol-Myers Squibb Company, Baxter International Inc., Pfizer Inc., GlaxoSmithKline plc Sponsored ... Read more (Read more...)

  • Ligand Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : LGND-US : April 26, 2017
    Capital Cube4 days ago

    Ligand Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : LGND-US : April 26, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Ligand Pharmaceuticals, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving ... Read more (Read more...)

  • Business Wire17 days ago

    Ligand to Report First Quarter 2017 Results on May 9th

    Ligand Pharmaceuticals Incorporated announced today plans to report first quarter 2017 financial results on May 9, 2017. Ligand’s CEO John Higgins, President and COO Matt Foehr and CFO Matt Korenberg will host the conference call.